476 related articles for article (PubMed ID: 15499297)
1. An in vitro study to compare 99mTc-stannous colloids and 99mTc-HMPAO for labelling human leukocytes.
Capriotti G; D'Alessandria C; Garin E; Weber E; Devillers A; Lehmann K; Corsetti F; Lecloirec J; Meller J; Becker W; Moisan A; Signore A
Q J Nucl Med Mol Imaging; 2004 Sep; 48(3):229-36. PubMed ID: 15499297
[TBL] [Abstract][Full Text] [Related]
2. A new 99mTc labelling method for leucocytes: in vitro and in vivo comparison with 99mTc-HMPAO.
Welling M; Feitsma HI; Blok D; Calame W; Ensing GJ; Goedemans W; Pauwels EK
Q J Nucl Med; 1995 Jun; 39(2):89-98. PubMed ID: 8574810
[TBL] [Abstract][Full Text] [Related]
3. 111In-oxine and 99mTc-HMPAO labelling of antigen-loaded dendritic cells: in vivo imaging and influence on motility and actin content.
Blocklet D; Toungouz M; Kiss R; Lambermont M; Velu T; Duriau D; Goldman M; Goldman S
Eur J Nucl Med Mol Imaging; 2003 Mar; 30(3):440-7. PubMed ID: 12722741
[TBL] [Abstract][Full Text] [Related]
4. Development and testing of a new disposable sterile device for labelling white blood cells.
Signore A; Glaudemans AW; Malviya G; Lazzeri E; Prandini N; Viglietti AL; De Vries EF; Dierckx RA
Q J Nucl Med Mol Imaging; 2012 Aug; 56(4):400-8. PubMed ID: 23013669
[TBL] [Abstract][Full Text] [Related]
5. Labelling and Clinical Performance of Human Leukocytes Labelled with
Auletta S; Riolo D; Varani M; Lauri C; Galli F; Signore A
Contrast Media Mol Imaging; 2019; 2019():4368342. PubMed ID: 31019414
[TBL] [Abstract][Full Text] [Related]
6. Study of Binding Kinetics and Specificity of
Auletta S; Iodice V; Galli F; Lepareur N; Devillers A; Signore A
Contrast Media Mol Imaging; 2018; 2018():5603902. PubMed ID: 30498401
[TBL] [Abstract][Full Text] [Related]
7. New synthesis route of active substance d,l-HMPAO for preparation Technetium Tc99m Exametazime.
Pijarowska-Kruszyna J; Karczmarczyk U; Jaroń AW; Laszuk E; Radzik M; Garnuszek P; Mikołajczak R
Nucl Med Rev Cent East Eur; 2017; 20(2):88-94. PubMed ID: 28555448
[TBL] [Abstract][Full Text] [Related]
8. HMGB1 expression in leukocytes as a biomarker of cellular damage induced by [
Follacchio GA; Manganelli V; Monteleone F; Sorice M; Garofalo T; Liberatore M
Nucl Med Biol; 2021; 96-97():94-100. PubMed ID: 33864964
[TBL] [Abstract][Full Text] [Related]
9. The value of quantitative uptake of (99m)Tc-MDP and (99m)Tc-HMPAO white blood cells in detecting osteomyelitis in violated peripheral bones.
Ballani NS; Al-Huda FA; Khan HA; Al-Mohannadi S; Mahmood H; Al-Enezi F
J Nucl Med Technol; 2007 Jun; 35(2):91-5. PubMed ID: 17496004
[TBL] [Abstract][Full Text] [Related]
10. 99mTc-SnF2 colloid "LLK": particle size, morphology and leucocyte labelling behaviour.
McClelland CM; Onuegbulem E; Carter NJ; Leahy M; O'Doherty MJ; Pooley FD; O'Doherty T; Newsam RJ; Ensing GJ; Blower PJ
Nucl Med Commun; 2003 Feb; 24(2):191-202. PubMed ID: 12548044
[TBL] [Abstract][Full Text] [Related]
11. Succinylated gelatine: an alternative to hydroxyethyl starch for labelling leukocytes with 99mTc-HMPAO.
Roca M; Armero F; Jiménez I; Rodríguez-Gasén A; Díaz C; Martín-Comín J
Nucl Med Commun; 2005 Aug; 26(8):749-52. PubMed ID: 16000996
[TBL] [Abstract][Full Text] [Related]
12. [Stabilization of 99m Tc-HMPAO with methylene blue: its use in leukocyte labelling)].
García Seguí V; Roca Engroñat M; Armero Muñoz F; Iglesias Allende F; Gomes Barreto de Mélo V; Martin-Comín J
Rev Esp Med Nucl; 1998; 17(4):261-4. PubMed ID: 9721341
[TBL] [Abstract][Full Text] [Related]
13. Media Fill Test for validation of autologous leukocytes separation and labelling by (99m)Tc-HmPAO.
Urbano N; Modoni S; Schillaci O
Nucl Med Biol; 2013 Jan; 40(1):104-8. PubMed ID: 23078874
[TBL] [Abstract][Full Text] [Related]
14. In vitro assessment of cytotoxicity and labeling efficiency of 99mTc-HMPAO with stromal vascular fraction of adipose tissue.
Verma VK; Beevi SS; Tabassum A; Kumaresan K; Kamaraju RS; Arbab AS; Chelluri LK
Nucl Med Biol; 2014 Oct; 41(9):744-8. PubMed ID: 25037755
[TBL] [Abstract][Full Text] [Related]
15. A comparative study of 99Tcm-HMPAO and 99Tcm-ECD as a leukocyte labelling agent.
Kao CH; Huang WT; Wang YL; Lin KS; Lo JM; Wang SJ
Nucl Med Commun; 1994 Apr; 15(4):294-7. PubMed ID: 8072744
[TBL] [Abstract][Full Text] [Related]
16. Stabilization of Tc-99m D,L-HMPAO preparations as a leucocyte labelling agent.
Kao CH; Huang WT; Tsai CS
Appl Radiat Isot; 1998 Dec; 49(12):1595-8. PubMed ID: 9745694
[TBL] [Abstract][Full Text] [Related]
17. Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections.
Erba PA; Sollini M; Conti U; Bandera F; Tascini C; De Tommasi SM; Zucchelli G; Doria R; Menichetti F; Bongiorni MG; Lazzeri E; Mariani G
JACC Cardiovasc Imaging; 2013 Oct; 6(10):1075-1086. PubMed ID: 24011775
[TBL] [Abstract][Full Text] [Related]
18. A high-efficiency, rapid and multi-dose procedure for white blood cell labelling with 99Tcm-HMPAO.
Ozker K; Collier BD; Hellman RS; Isitman AT; Krasnow AZ; Uzum F; Steffel FS
Nucl Med Commun; 1996 Apr; 17(4):342-5. PubMed ID: 8786871
[TBL] [Abstract][Full Text] [Related]
19. 99mTc-HMPAO labelling inhibits cell motility and cell proliferation and induces apoptosis of NC-NC cells.
Ulker O; Genç S; Ateş H; Durak H; Atabey N
Mutat Res; 2007 Jul; 631(2):69-76. PubMed ID: 17512775
[TBL] [Abstract][Full Text] [Related]
20. Assessment of inflammatory bowel disease by using two different (99m)Tc leucocyte labelling methods.
Cardoso VN; Plaza PJ; Roca M; Armero F; Martín-Comin J
Nucl Med Commun; 2002 Aug; 23(8):715-20. PubMed ID: 12124475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
